GC Pharma pledges free Covid-19 treatment, if it's approved

Home > Business > Industry

print dictionary print

GC Pharma pledges free Covid-19 treatment, if it's approved

GC Pharma on Monday promised to offer its Covid-19 treatments for free to patients in Korea once it completes development.
 
The Yongin, Gyeonggi-based pharmaceutical company's treatment candidate, called GC5131A, is a hyperimmune globulin that is made with immune proteins collected from recovered Covid-19 patients.
GC is the first Korean drugmaker to make such a pledge about a potential Covid-19 treatment.  
 
The decision, the company said, is intended to contribute to public health efforts to rein in the coronavirus pandemic, adding that it won’t place any cap on the quantity of the treatments to be circulated.  
 
The pharmaceutical unit is hoping for commercialization the drug by the second half of 2020.
 
BY PARK EUN-JEE [park.eunjee@joongang.co.kr]

More in Industry

Chuseok delivery strike canceled as headcount increased

BMW Motorrad channels 1936 for its latest bike

Battery business IPO won't affect LG Chem's controlling stake, company says

Hyundai Construction Equipment signs Algeria forklift deal

FSS permits financial sector workers to use networks remotely

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now